AngelEye Health, a leader in neonatal and pediatric services, today announced the closing of a $9 million Series C funding round. In addition to the equity financing, AngelEye has secured a complementary debt facility from Live Oak Bank to strategically extend the company’s growth capital. The combined funding will enable AngelEye to accelerate product innovation, expand its commercial footprint, and further advance its mission to transform neonatal and pediatric inpatient units into intelligent, connected environments optimized for care delivery, efficiency, and family empowerment.
The round was led by existing investor Mountain Group Partners, with continued support from Brad Whitmore and additional existing investors. AngelEye welcomed Nationwide Children’s Hospital as a new investor, underscoring a shared commitment to improving outcomes for vulnerable infants. In conjunction with the investment, Luke Brown, Vice President of Finance and Treasury at Nationwide Children’s Hospital will join AngelEye’s Board of Directors as an observer.
“AngelEye’s mission to empower families and equip care teams in the NICU and pediatric settings aligns strongly with our goals as a pediatric health leader,” said Mr. Brown.
The company is proud to announce that with the increasing adoption of its platform, AngelEye now provides services to over 350 hospitals who serve approximately 20% of the NICU families across the United States. Additionally, the Series C announcement follows several significant 2025 milestones for AngelEye, including its fourth consecutive appearance on the Inc. 5000 list of America’s fastest-growing private companies, recognition as an Inc. Power Partner, and the achievement of SOC II Type 2 certification.
“Our team has remained focused on one mission: helping hospitals provide comprehensive support for clinical teams and families alike, equipping them with the tools they need to stay connected, confident, and informed throughout the NICU journey,” said Christopher Rand, CEO of AngelEye Health. “This funding gives us the ability to bring AIVision to market while continuing to scale the solutions that have already made us a trusted partner to hundreds of hospitals nationwide.”
AngelEye’s platform has become a mainstay in NICU and PICU environments, enabling real-time family connection through secure livestream video, streamlining feeding workflows and documentation with MilkTracker, and guiding families through discharge readiness with NICU2Home. With the addition of AIVision, the company is advancing its value proposition by providing care teams with earlier, AI-driven insights, reinforcing its role as a critical partner in patient safety, family engagement, and operational efficiency.